Novo Holdings A/S’s Neuronetics STIM Stock Holding History

Novo Holdings A/S’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-514,190	Closed	-$992K	–	43
2020 Q2	$992K	Sell	514,190 -388,682	-43%	-$797K	0.06%	35
2020 Q1	$1.71M	Buy	902,872 +166,294	+23%	+$520K	0.11%	30
2019 Q4	$3.31M	Buy	736,578 +108,230	+17%	+$672K	0.21%	26
2019 Q3	$5.22M	Buy	628,348 +45,550	+8%	+$498K	0.89%	20
2019 Q2	$7.29M	Buy	582,798 +57,798	+11%	+$817K	1.02%	18
2019 Q1	$8.01M	Hold	525,000	–	–	1.18%	16
2018 Q4	$10.2M	Hold	525,000	–	–	1.43%	12
2018 Q3	$16.8M	Buy	+525,000	New	+$16M	1.34%	12

Other funds holding STIM

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Novo Holdings A/S's STIM Position: Q3 2020 in Review

Novo Holdings A/S sold out of Neuronetics (STIM) in Q3 2020, closing a stake of 514,190 shares — an estimated $992K sold.

Novo Holdings A/S first reported a position in STIM in Q3 2018 and held it in 8 quarters. The position peaked at $16.8M in Q3 2018. 55 funds tracked by Wall St. Rank hold STIM as of Q3 2020.

Novo Holdings A/S reported no remaining Neuronetics position as of Q3 2020 after selling out during the quarter.
Novo Holdings A/S sold 514,190 Neuronetics shares in Q3 2020, an estimated $992K.
Novo Holdings A/S first reported a position in Neuronetics in Q3 2018 and held it in 8 quarters.
Novo Holdings A/S's Neuronetics position peaked at $16.8M in Q3 2018.
55 funds tracked by Wall St. Rank held Neuronetics as of Q3 2020.

Based on Novo Holdings A/S's 13F filing for Q3 2020, filed 16 Nov 2020.